Standardising personalised diabetes care across European health settings: A person‐centred outcome set agreed in a multinational Delphi study

Abstract

ObjectiveStandardised person‐reported outcomes (PRO) data can contextualise clinical outcomes enabling precision diabetes monitoring and care. Comprehensive outcome sets can guide this process, but their implementation in routine diabetes care has remained challenging and unsuccessful at international level. We aimed to address this by developing a person‐centred outcome set for Type 1 and Type 2 diabetes, using a methodology with prospects for increased implementability and sustainability in international health settings.MethodsWe used a three‐round questionnaire‐based Delphi study to reach consensus on the outcome set. We invited key stakeholders from 19 countries via purposive snowball sampling, namely people with diabetes (N = 94), healthcare professionals (N = 65), industry (N = 22) and health authorities (N = 3), to vote on the relevance and measurement frequency of 64 previously identified clinical and person‐reported outcomes. Subsequent consensus meetings concluded the study.ResultsThe list of preliminary outcomes was shortlisted via the consensus process to 46 outcomes (27 clinical outcomes and 19 PROs). Two main collection times were recommended: (1) linked to a medical visit (e.g. diabetes‐specific well‐being, symptoms and psychological health) and (2) annually (e.g. clinical data, general well‐being and diabetes self management‐related outcomes).ConclusionsPROs are often considered in a non‐standardised way in routine diabetes care. We propose a person‐centred outcome set for diabetes, specifically considering psychosocial and behavioural aspects, which was agreed by four international key stakeholder groups. It guides standardised collection of meaningful outcomes at scale, supporting individual and population level healthcare decision making. It will be implemented and tested in Europe as part of the H2O project.

Are we ready for an adipocentric approach in people living with type 2 diabetes and chronic kidney disease?

“…Gender differences, social determinants of health and the promotion of interdisciplinary care are also important. If we include all these factors in the shared decision-making process, clinical outcomes are likely to be better and adherence and persistence may be improved [ 71 ].…”

Asking women with diabetes about sexual problems: An exploratory study of NHS professionals' attitudes and practice

“…2 The review called on healthcare professionals (HCPs) to discuss sexual problems within clinical consultations and for awareness that FSD may be linked to advanced diabetes complications. A Delphi review highlighted the importance of sexual health (including sexual dysfunction) to people with diabetes 3 and a systematic review concluded FSD is a significant issue for women with type 1 diabetes. 4 According to Diagnostic and Statistics Manual V, 5 FSD describes a disorder of sexual interest/−arousal and/or genitopelvic pain/penetration, and/or orgasm.…”